IGC Pharma, Inc.
For the period ended Dec 2, 2026. Filed Oct 22, 2026.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Dec 2, 2026 · Filed Oct 22, 2026
Contents
Effect of the Amendment
If Proposal Two is approved, the annual adjustment to the share reserve under Section 4.1 of the 2018 Incentive Plan will occur on January 1 of each year, commencing January 1, 2027, instead of April 1.
If Proposal Two is approved but Proposal Three is not approved, the existing 15% percentage will continue to apply, but the annual share reserve adjustment will occur on January 1.
Approval of Proposal Two is not conditioned upon approval of Proposal Three.
The amendment will not extend the existing term of the 2018 Incentive Plan and will not otherwise modify the Plan except as described in this Proposal Two.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.